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Abstract 
The review is devoted to the medical application of montmorillonite clay minerals.  
Properties and mechanisms of action of enterosorbents. The properties of the enterosorbents 
include an absorption capacity and active surface. The mechanisms of action include the sorption 
of toxins in the gastrointestinal tract, the contact effect on the mucosa, enhancing the release of 
toxins in the gastrointestinal tract, increasing the metabolism and excretion of toxins. 
Physico-chemical properties of montmorillonite. Montmorillonite is a layered silicate from the 
smectite group, with the structure of 2:1. Its specific area is 173 m
2
/g and sorption capacity is 370 
mg/g.  
The application of montmorillonite clays in medicine. Smectites are used as excipients, active 
substances or dispersants. 
Oral effects of smectite. The smectite based enterosorbents have antacid, mucocytoprotective, 
antidiarrheal effects, a high sorption activity against bacterial and viral particles. 
Analysis of the clinical use of the smectite based enterosorbents. Diosmectite has a high 
strength of recommendations and security (class B). The analysis is based on the results of the 
randomized clinical trials. According to different authors, from 22 to 84% of European doctors 
prescribe smectite for acute diarrhoea. Smectite reduces the duration of diarrhea by 22-42%, 
significantly reducing the number of bowel movements in comparison with placebo (p<0.001). 
The drug is well tolerated and has no side effects. 
Key words: montmorillonite; smectite; medical clays; layered aluminosilicates; enterosorbents. 
Introduction 
Efferent therapy as a method of elimination of 
toxic products from the body's environment is 
gaining popularity in various branches of clinical 
medicine. Among all the methods of efferent therapy, 
this method of non-invasive detoxification as 
enterosorption attracts close attention, which, with 
adequate use, allows achieving a local and systemic 
positive effect. 
Removal of compounds that negatively affect 
the body, such as allergens, active peroxides, viruses, 
toxins, inflammatory mediators, as well as preventing 
their movement into the systemic bloodstream, 
stimulates the mechanisms of resistance of the 
organism, prevents the development of excessive 
inflammatory reactions, improves metabolism [1, 2]. 
Adsorption is a process that occurs on the phase 
separation when a gas or liquid substance accumulates 
on the surface of a solid or liquid (adsorbent), forming a 
molecular or atomic film (adsorbate) [3]. Typically, the 
adsorbent has a fixed total absorption, where a 
particular solute is replaced by another, for example, in 
ion exchange processes. When the adsorbent is in 
contact with a liquid containing the substance to be 
absorbed, adsorption occurs until equilibrium is reached 
or when the surface of the adsorbent is saturated with 
adsorbate [4]. 
The adsorption process can be divided into two 
main types, namely the physical and the chemical, 
which are sometimes called physiosorption and 
chemisorption, respectively. The difference between 
the two types of adsorption is that during physical 
adsorption, the adsorbate adheres to the surface 
Rus. 
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through weak intermolecular interactions, such as 
van der Waals forces, hydrophobicity, hydrogen 
bonds, polarity, static interactions, and dipole-dipole 
interactions [5]. On the other hand, during 
chemisorption, molecules attach to the surface, 
forming a chemical bond through electronic 
exchange [6]. 
Properties and mechanisms of action of 
enterosorbents 
Enterosorbents have a number of basic 
characteristics, namely: sorption capacity – the amount 
of a substance that can bind a sorbent per unit of its 
mass (mg/g); Active surface – the total area of the 
adsorbing surface per unit mass (m
2
/g); The sorbent's 
ability to bind various sorbate molecules of different 
mass and size, including bacterial agents [7, 8]. 
As a rule, the more sorption surface of the 
sorbent, the higher its sorption capacity [9, 10]. 
However, it should be noted that the sorption 
capacity of the sorbent, determined "in vitro", can 
significantly differ from that in clinical practice. In 
this respect, a study conducted by P.L. Shcherbakov 
and V.A. Petukhov in 2005 is indicative. When 
analyzing the sorption activity of enterosorbents with 
respect to the endotoxin Salmonella abortus, the 
maximum absorption rate was recorded in smectite 
dioctahedral (Smecta
®
) having a lower sorption 
surface (100 m
2
/g) than methyl silicic acid hydrogel 
(150 m
2
/g), known under the trade name Enterosgel
®
, 
which showed a lower rate of endotoxin sorption 
[11]. This allows us to reflect on the compliance of 
technical laboratory characteristics of sorbents and 
their sorption efficiency with respect to biological 
objects. In addition, in some works it is pointed out 
that in some cases clay sorbents with a lower active 
area show a much more pronounced sorption 
capacity. This applies mainly to montmorillonite, 
which has an active area of 173 m
2
/g and a sorption 
capacity of 370 mg/g, which is much higher than that 
of all native clays under study [12]. 
The main mechanisms of action of agents used 
for enterosorption include the following four groups. 
The first group of mechanisms concerns direct 
interaction and sorption in the lumen of the 
gastrointestinal tract of toxic products, exo- and 
endotoxins, pathogenic and conditionally pathogenic 
microorganisms, possible allergens. This applies to 
xenobiotics and metabolites both trapped in the 
lumen of the gastrointestinal tract from the outside, 
and formed in the lumen of the intestine. The second 
group refers to the contact effect on the structures of 
the gastrointestinal tract, including the effect on the 
enzymatic composition of the gastrointestinal 
mucosa, the content of various substances having 
biological activity in the intestinal tissues and, as a 
consequence, a change in the functional state of the 
gastrointestinal tract. The third group is the 
stimulation of the release of endotoxins from the 
systemic blood stream and internal media into the 
lumen of the gastrointestinal tract by direct diffusion 
from the blood and/or to a greater extent with 
digestive juices. The fourth group of mechanisms 
includes indirectly enhancing the exchange and 
excretion of toxins by detoxifying organs, as well as 
fixing and transferring biologically active substances, 
such as enzymes and bile acids to the surface of 
enterosorbent [7, 13, 14, 15]. 
Physico-chemical properties of 
montmorillonite 
To date, a lot of interest is caused by 
enterosorbents based on clay minerals belonging to 
the subclass of smectites [16, 17, 18, 19, 20, 21, 22]. 
Almost 90% of world production of smectites is 
concentrated in 22 countries, including Australia, 
Mexico, Russia, South Africa, USA [23]. 
Enteric sorbents based on smectite clays are 
characterized by the ability to exert a soft effect on 
the mucous barrier, not to bind cells of the normal 
microflora of the gastrointestinal tract and 
physiologically valuable nutrients, to not disturb the 
secretion processes, to improve rheological properties 
of mucus and immunity parameters [1, 24, 25]. 
Montmorillonite refers to layered clay minerals 
of the smectite group with a high content of SiO2 
and Al2O3 with a 2:1 structure. This means that the 
unit cell of this clay mineral consists of three 
sheets of crystal lattices of a tetrahedral and 
octahedral structure. The crystal lattice includes an 
aluminum-oxygen and aluminum-hydroxyl-
octahedral sheet sandwiched between two silicon-
oxygen tetrahedral sheets (Fig. 1). The structure of 
the triple sheet is composed of layers connected by 
van der Waals forces [26, 27, 28, 29, 31]. The 
thickness of the layer is about 1 nm, and the 
transverse dimensions of these layers vary from 
100 nm to 1000 nm [20, 30, 31, 32, 33]. The unit 
cell of montmorillonite includes four octahedral 
sites and eight tetrahedral sites, that is, 
montmorillonite belongs to the subclass of 
dioctahedral smectites. This is due to the fact that 
trivalent cations prevail in its octahedral layer, 
such as aluminum and iron cations [34, 35, 36, 37, 
38]. The ideal theoretical formula for 
montmorillonite is as follows: 
210
4
4
23
22 )())(( OHOSiMgAlOnHM yyy


  , where 
M
+
 refers to a monovalent cation in the interlayer 
space, but in reality the composition of 
montmorillonite differs from the theoretical formula 
due to the substitution of a number of cations for 
others [33, 39]. 
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Fig. 1. Model of the structure of montmorillonite layers 
[32] 
On the external surface of montmorillonite there 
are both interlayer and ionized hydroxyl centers [40]. 
Cations in the tetrahedral sheet are usually Si
4+
 and 
Al
3+
, in the octahedral sheet – Al3+, Fe3+, Mg2+. 
Because of the isomorphous substitution of cations in 
both tetrahedral (Si
4+
) and/or octahedral (Al
3+
, Fe
3+
, 
Mg
2+
) sheets by lower valence cations, the layered 
structure acquires a constant common negative 
charge, which is balanced by cation exchange within 
the interlayer space [31, 33, 41]. Negative charge 
contributes to the ability of the clay to adsorb 
positively charged ions. In addition, the adsorption 
characteristics of clays are due to their large pore size 
and surface area. These factors affect the physical 
properties of montmorillonite, such as the sorption 
surface and the sorption capacity [42, 43, 44]. The 
phenomena that occur on the surfaces of the clay give 
them high flexibility in adsorption processes. The 
nature of the surface includes the structure, ion 
exchange capacity, specific surface area, mechanical 
and chemical stability, water retention and surface 
reactivity, which affects the physical and chemical 
properties of clay minerals [45, 46]. As a rule, clays 
have replaceable ions on their surface [45]. The inter-
pack space of montmorillonite contains exchange 
cations of alkali and alkaline-earth metals and water 
molecules. This characteristic leads to the fact that 
clays play a decisive role in the environment, being 
natural adsorbents of pollutants. Cation exchange 
occurs easily, without affecting the structure of the 
clay mineral [47]. 
Depending on the prevalence of the exchange 
cation in the crystal lattice structure: 
Montmorillonites can be of sodium or calcium type 
[37]. Calcium montmorillonite is the most common 
of smectites and is found in many geographical 
places of the world. Sodium montmorillonite is 
relatively rare compared to calcium montmorillonite, 
and it swells more in water than calcium 
montmorillonite [48, 49]. The presence of an 
exchange cation (sodium, calcium) increases the 
distance between the layers of montmorillonite 
structures, and as a consequence, ensures the 
penetration of water molecules between them [50]. 
Montmorillonite possesses high sorption 
properties due to its structural characteristics. The 
main characteristics of this material are high internal 
surface area, high adsorption capacity, high cation 
exchange capacity, swelling, low hydraulic 
conductivity and low toxicity [42, 51, 52, 53, 54]. 
Usually, these clay materials are used as natural 
materials, since they are not subjected to a chemical 
change. Nevertheless, chemical modification can 
improve the adsorption capacity of clay, which leads 
to its wide use in new technologies [44, 55, 56]. 
Chemical treatment of clay can change its 
structure, texture and / or other properties [57]. 
Indeed, clay minerals are usually classified into 
natural clays, clays subjected to activation (alkaline 
or acid treatment) and organic clays (treatment with 
organic substances) [58]. 
Alkaline activation is usually carried out by 
treatment with sodium carbonate (soda). Activation 
of 2-4% of soda is traditionally used to treat low-
quality smectites in industry [59]. 
Acidic activation of smectite clays with the help of 
hydrochloric and sulfuric acids leads to a change in 
their composition, surface area and porosity, and also to 
an increase in their absorbing properties [60, 61, 62]. In 
addition, acid treatment removes calcium ions from the 
surfaces and edge regions of the layers, which increases 
the total negative charge [63, 64, 65]. 
Organic smectite clays are obtained by 
modifying clays with quaternary ammonium cations 
by cation exchange [49]. During this procedure, the 
hydrated cations (Na
+
, K
+
, Ca
2+
, Mg
2+
) that neutralize 
the excess negative charge arising from isomorphous 
substitution in silicon tetrahedra and/or aluminum 
octahedra are replaced by cations of quaternary 
ammonium in the interlayer space [66]. Inorganic 
cations are gradually replaced by organic cations. 
Thus, the surface of organic smectite changes from 
highly hydrophilic to hydrophobic [67, 68]. 
The administration of montmorillonite clays 
in medicine 
Montmorillonite clays due to their properties are 
widely used in medicine and the pharmaceutical 
industry. For this reason, they are often called 
medical clays [17]. Smectites are commonly used in 
the pharmaceutical industry as excipients, active 
substances or dispersants that perform technological 
functions [48, 69, 70]. New fillers with very specific 
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goals are added to most new medicines. Such targets 
are varied to include a decrease or increase in 
dissolution rate, drug release delay, drug release 
targeting (biopharmaceutical targets), prevention or 
reduction of side effects (pharmacological targets), 
taste masking or stability improvement 
(technological objectives) [70, 71, 72]. 
Montmorillonite has attracted much attention 
due to its ability to allocate drugs in a controlled way, 
its mucoadhesives and strong detoxification effect, 
which ultimately leads to high drug efficiency [26, 
29, 73]. Moreover, the use of montmorillonite 
corrects gastrointestinal disorders, one of the most 
common side effects of cancer chemotherapy [27, 70, 
74, 75]. 
Clay minerals are also used as active ingredients 
in cosmetic products, such as face masks, due to the 
high content of absorbent substances that contribute 
to the removal of fats and toxins from the skin 
surface [71]. Therefore, they are recommended for 
inflammatory processes such as furuncles, acne and 
ulcers, as antiperspirants, to make the skin opaque, 
remove gloss and pigment spots from the skin surface 
[71, 76]. 
In addition, medical clays used in creams, 
powders or emulsions contribute to an increase in the 
amount of collagen fibers in the skin, suggesting that 
the protective mechanism of smectite appears to be 
mediated by a combination of allergen uptake and 
improved skin barrier function, and by providing a 
physical barrier Against ultraviolet radiation [77]. 
Oral effects of smectite 
Oral application of clays in the treatment of 
certain diseases is based on the ability of clay and 
clay minerals to sorb, retain and eliminate 
xenobiotics, microorganisms and toxic products of 
their activity, toxic digestive products, gases, food 
allergens. A number of studies have shown the 
positive effect of preparations based on clay minerals 
in the treatment of a number of pathological 
conditions, mainly in diseases of the gastrointestinal 
tract [78]. The use of clay as a medicine, and also as 
a food additive has an ancient history. Oral 
application of clays (“geophagia”) has been practiced 
since antiquity in all parts of the world. Among the 
whole variety of clay minerals, in ancient times 
primitive tribes mainly used clays with a high content 
of montmorillonite to prevent stomach pain, digestive 
disorders, burn treatment, reduce gastric acidity, 
improve taste qualities [79, 80]. To this day in many 
areas of the world, clay minerals are used for food. 
There are several reasons for geophagy: 1. 
detoxification, or at least improvement in the taste of 
foods containing unwanted components;                  
2. alleviation of gastrointestinal disorders such as
diarrhea; 3. Preparation of mineral additives, in 
particular iron and calcium; 4. as an antacid to 
remove excess acidity in the digestive tract. These 
reasons make geophagy culturally acceptable in the 
modern world [81]. In general, of all clays, smectites 
(including montmorillonite) are considered more 
reactive in the gastrointestinal tract [82]. 
Smectites, including montmorillonite after oral 
ingestion has an antacid, antidiarrhoeal, 
cytoprotective against the mucosa of the 
gastrointestinal tract properties. 
The increased acidity in the stomach resulting 
from excessive formation of hydrochloric acid by 
parietal cells of the gastric fundal glands can be 
effectively reduced by oral use of non-systemic 
antacids, such as montmorillonite-based enterosorbents. 
Clay minerals have an antacid effect through two 
mechanisms: (a) the direct neutralization of 
hydrochloric acid in the stomach and (b) the adsorption 
of H + ions on the surface of the enterosorbent. The 
antacid effect of montmorillonite clays is due to a 
second mechanism, that is, the sorption of hydrogen 
cations on the surface, as well as in the interlayer space 
of the mineral. The main centers of interaction of 
montmorillonite and hydrogen cations are the structural 
cations of the octahedral and tetrahedral layers (Mg
2+
, 
Al
3+
), as well as the interlayer space and cations located 
in it [83, 84]. 
Clays from the smectite group, when 
administered orally, have a stabilizing effect on the 
barrier functions of the gastrointestinal mucosa, 
interacting directly with mucus elements. Thus, clay 
minerals improve the protection of the mucosa from 
aggressive factors acting on the mucosa of the 
gastrointestinal tract [85, 86, 87]. 
When interacting with mucus in the 
gastrointestinal tract, smectite forms a protective film 
on the mucosal surface, which reduces the aggressive 
action of the stomach environment. In addition, it 
sorbs gases, toxins, bacteria and viruses. The 
mechanism of protective action is to increase the 
viscosity of mucus and inhibit the degradation of 
glycoproteins that make up its composition. Smectite 
reduces the destruction of mucus by bacteria and 
disruption of the integrity of membranes of 
enterocytes, which causes normalization of the water-
electrolyte balance and absorption of nutrients [88, 
89]. At the moment in Russia smectite is the only 
enterosorbent with proven cytoprotective properties 
[11]. 
Diarrhea is an acute or chronic pathological 
condition in which there is increased fluid formation 
in the lumen of the gastrointestinal tract and its rapid 
evacuation by natural means. This is manifested by a 
rapid liquid stool, abdominal pain, increased gas 
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production. Diarrhea can be caused by bacterial 
infection, intoxication, inadequate intestinal 
absorption, allergy, etc. In this regard, smectite is 
widely used to stop diarrhea, sorbing excess fluid, 
gases, bacterial toxins in the lumen of the 
gastrointestinal tract, contributing to the reduction of 
inflammation in the wall of the small and large 
intestine [25, 90, 91]. 
In vitro conditions, smectite and psyllium have 
been found to possess the highest sorptive capacity 
for S.enteritidis and E.coli. The smectite results were 
better not only in the number of adsorbed bacterial 
cells, but also in the number of cells remaining in the 
solution after removal of the sorbent [92]. In the 
experiment, the high sorption ability of smectite was 
also shown for some other gram-positive bacteria 
(V.cholerae, C.jejuni, C.difficile, Shigella sonnei), 
their toxins and metabolites, and also for rotavirus. 
Smectite is able to fix on its surface and eliminate up 
to 90% of viral particles [11, 93, 94, 95]. 
In addition, enterosorbents have the ability to the 
so-called distant action, which manifests itself in the 
change of various biochemical parameters in tissues 
and organs, far removed from the gastrointestinal 
tract. This mainly relates to changes in the functional 
state of the liver, reduction of the total cholesterol in 
the blood, the appearance of an immunomodulatory 
effect associated with a decrease in antigenic effect 
due to improved proteolysis in the food lump [14]. 
It should be especially noted that enterosorbents 
are not absorbed in the gastrointestinal tract, and, as a 
consequence, do not have a resorptive effect. This 
property is fundamental for enterosorbents and is 
presented with the main requirement on a par with 
the absence of toxicity in the search for new 
substances for enterosorbents. 
Analysis of the clinical administration of 
smectite based enterosorbents 
Based on data from evidence-based medicine, it 
can be said with certainty that sorption therapy with 
smectite-based drugs is widely used in clinical 
medicine to treat diseases associated with 
endogenous intoxication syndrome in both children 
and adults, including pregnant women. It should be 
noted that among all enterosorbents in acute 
gastroenteritis in children and adults, only 
dioctahedral smectite has a high degree of evidence 
and safety (class B) [96, 97, 98]. 
Trust in enterosorbents based on smectite 
dioctahedral is extremely high among doctors. This is 
true both for developing countries and for developed 
countries. So Szajewska (2000) points out that 22% 
of doctors in European countries use smectite to treat 
gastroenteritis in children as an adjuvant therapy. 
According to Uhlen (2004), the use of smectite by 
French pediatricians in private medicine reaches 
84%. In clinics in Prague, about 46% of children with 
acute diarrhea received smectite (Kudlova, 2010). 
Hou (2013), based on the analysis of appointment 
sheets in 20 hospitals in two provinces of China, 
notes that almost two thirds of adults suffering from 
acute infectious diarrhea have been prescribed 
diosmectitis [99]. 
As a result of a multicenter, randomized, 
double-blind, placebo-controlled study, dioctahedral 
smectite has a high oral efficacy for the treatment of 
acute diarrhea in adults compared to the placebo 
group, which was manifested by a reduction in the 
timing of recovery. In this case the drug was well 
tolerated, and the patients did not notice any negative 
side effects [100]. 
When testing the safety and tolerability of 
NovaSil
®
 enterosorbent, which contains dioctahedral 
smectite, which was used at a high risk of 
aflatoxicosis in Ghana, no side effects of the drug 
were found. During the study, 0.5% reported nausea, 
diarrhea, heartburn, and dizziness with both NovaSil
®
 
and placebo, indicating high safety when using 
dioctahedral smectite [19, 101, 102]. 
Diosmectit is one of the most effective and safe 
antidiarrheal agents that can be used in children as an 
adjunctive therapy to oral rehydration to reduce the 
timing of diarrhea and reduce its volume. This was 
shown in two parallel, double-blind clinical trials 
with the participation of 602 children aged 1 to 36 
months with acute diarrhea and dehydration 
symptoms, which were conducted in Malaysia Peru. 
Children received diosmectite at a dose of 6 g per day 
between 1 and 12 months and 12 g per day between 
the ages of 13 and 36 months for 3 days, with a 
decrease in dose twice in the following days until 
relief of signs of diarrhea or placebo. The results 
were presented separately for two groups of the 
population. In Peru, in the diosmetic group compared 
to the placebo group, the total amount of stool at the 
72nd hour of treatment was reduced (102.0±65.5 
g/kg versus 118.8±92.5 g/kg, p=0.032) and more 
Short duration of diarrhea (68.17 h against 118.92 h, 
p=0.001). Positive effect of diosmectite was exposed 
to both rotavirus-positive and rotavirus-negative 
children. In Malaysia, the 72 hour mass was also 
significantly lower in the group receiving 
diosmectitis than in the placebo group (87.9±81.2 
g/kg versus 90.7±94.0 g/kg, p=0.007). The duration 
of diarrhea was significantly reduced in children 
receiving diosmectitis than in the placebo group (25.1 
h versus 32.6 h, p=0.001). However, in this case, the 
Tishin A.N., Krut U.A., Tishina O.M., Beskhmelnitsyna E.A., Yakushev V.I. Physico-chemical properties 
of montmorillonite clays and their application in clinical practice (review)   Research result: 
pharmacology and clinical pharmacology. Vol. 3, №2 (2017): 119-128. 
124 
RESEARCH RESULT:  
PHARMACOLOGY AND CLINICAL PHARMACOLOGY 
positive effect of treatment with diosmectitis was 
observed only in rotavirus-negative children [103]. 
A later, open-label, randomized clinical trial in 
India found that dioctahedral smectite shortens the 
duration of diarrhea. In this study, 117 children aged 
2 to 5 years with acute diarrhea were prescribed 
diosmectitis in a dose of 1.5 g three times a day for 5 
days or placebo. Children who received smectite 
recovered more quickly than in the placebo group. 
This was manifested by a decrease in the resolution 
time of diarrhea (64.34±14.86 h against 82.37±21.43 
h, p<0.001). Thus, the results of numerous studies 
confirmed that smectite clay enterosorbents as a 
supplement to the standard rehydration therapy for 
acute diarrhea have high efficacy, which is indicated 
by a reduction in the timing of diarrhea resolution, a 
decrease in stool volumes, and a reduction in 
recovery time [104]. 
As a combined meta-analysis of nine randomized 
controlled trials has shown, smectite in children reduces 
the duration of diarrhea by an average of 23 hours, and, 
moreover, significantly reduces the total number of 
defecations in comparison with placebo. Treatment was 
accompanied by an increased likelihood of recovery on 
day 3, in addition, the use of smectite significantly 
reduces the likelihood of diarrhea lasting more than 7 
days. In all studies of side effects with short-term 
therapy with dioctahedral smectite was not found [96]. 
Conclusion 
Thus, evidence of the effectiveness of 
enterosorbents based on smectite clays is very wide 
in both developed and developing countries, when 
used in inpatient and outpatient settings. Mechanisms 
involved in the antidiarrheal effect include increased 
colonic mucin secretion and modulation of cytokine 
production by mucosal cells, as well as effects on 
intestinal permeability and secretion of electrolytes. 
In addition, montmorillonite has a 
mucocytoprotective effect, affects the production of 
enzymes and cytokines by cells of the gastrointestinal 
tract, has a variety of long-range effects, has a 
pronounced detoxification effect. 
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